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ABSTRACT The interaction of anthracyclines (daunorubicin and idarubicin) with monolayers of zwitterionic palmitoylo-
leoylphosphatidylcholine (POPC) and anionic dipalmitoylphosphatidic acid (POPC-DPPA 80–20 mol%) was studied by
surface pressure measurements and compared with previous results obtained with other anthracyclines (pirarubicin and
adriamycin). These anthracycline/phospholipid monolayers were next transferred by a Langmuir-Blodgett technique onto
planar supports and studied by surface-enhanced resonance Raman scattering (SERRS), which gave information about the
orientation of anthracycline in the monolayers. On the whole, the adsorption of anthracyclines in zwitterionic monolayers
increases with the anthracycline hydrophobic/hydrophilic balance, which underlines the role of the hydrophobic component
of the interaction. On the contrary, the anthracyclines remain adsorbed on the polar headgroups of the phospholipids in the
presence of DPPA and form a screen that limits a deeper penetration of other anthracycline molecules. To study by SERRS
measurements the crossing of pirarubicin through a phospholipid bilayer used as a membrane model, asymmetrical
POPC-DPPA/POPC or POPC/POPC-DPPA bilayers were transferred by the Langmuir-Scha¨fer method, thanks to a labora-
tory-built set-up, and put in contact with a pirarubicin aqueous solution. It has been shown that the presence of anionic DPPA
in the first monolayer in contact with pirarubicin would limit its crossing. This limiting effet is not observed if the first monolayer
is zwitterionic.
INTRODUCTION
Anthracyclines are antibiotics used in antitumor chemother-
apy. After the crossing of the cellular membrane by passive
diffusion, anthracyclines intercalate between the base pairs
of DNA, inhibiting the replication process of cells (Yunyu
et al., 1993). Anthracyclines are also able to interact with
the topoisomerase-DNA complex (Capranico et al., 1995).
A major problem appearing during treatment is the de-
velopment of cells that are resistant to the drug used and to
other molecules without any structural relation to the drug.
This is multidrug resistance (MDR), related to the overex-
pression in the membrane of a glycoprotein, the P-gp (Brad-
ley et al., 1988). This protein is an ATP-dependent pump
expelling the drug out of the cell: thus the intracellular
amount of anthracycline is not sufficient to inhibit cellular
growth. Under these conditions, there are two possible
solutions. The first consists of inhibiting the P-gp with
specific blockers, but the use of a second active molecule
during the treatment can be difficult. The second solution
consists of finding new derivatives of anthracyclines able to
cross the membrane more quickly: even if a part of the
anthracycline is expelled from the cell, the intracellular
amount would be sufficient to inhibit cellular growth. This
second solution implies a better understanding of anthracy-
cline-membrane interaction.
It has been shown that two types of interaction (electro-
static and hydrophobic) are involved in anthracycline-mem-
brane interaction. The interaction of anthracyclines with
zwitterionic phospholipids is limited, whereas the fixation is
more important in the presence of anionic lipids such as
cardiolipin (Goormaghtigh et al., 1980; Speelmans et al.,
1994). This latter specific and strong interaction could be
responsible for the cardiotoxicity of anthracyclines (Goor-
maghtigh et al., 1987). These results have also been ob-
served with adriamycin in contact with phospholipid mono-
layers, although the use of monolayers as a simplified
membrane model is not very common in this kind of study
(Goormaghtigh et al., 1980; Nicolay et al., 1988; Dupou-
Ce´zanne et al., 1989). The amount of anthracyclines in
contact with lipids also depends on the anthracycline/lipid
ratio. For instance, Ferrer-Montiel et al. (1988) have shown
that the localization of daunorubicin in cellular membranes
is deeper when the daunorubicin/lipid ratio is high; this
result is also obtained by circular dichroism with adriamy-
cin in interaction with liposomes containing egg-phospha-
tidic acid, egg-phosphatidylglycerol, or cardiolipin (Henry
et al., 1985). The presence of anionic phospholipids can also
change the permeability coefficient of anthracyclines:
Speelmans et al. (1994) observed, for instance, that the
permeability coefficient of adriamycin in DNA-containing
liposomes was decreased in the presence of anionic phos-
pholipids. They assigned this result to a tightening of the
phospholipid polar headgroups due to the presence of adri-
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amycin-anionic phospholipid complexes and proposed that
adriamycin would thus be adsorbed on the polar headgroups.
The work reported here includes two parts:
1. We first studied by surface pressure measurements
(Langmuir method) the interaction of two anthracyclines,
daunorubicin and idarubicin, with zwitterionic POPC
(palmitoyloleoylphosphatidylcholine) monolayers and an-
ionic POPC-DPPA (dipalmitoylphosphatidic acid) 80–20
mol% monolayers. This method enabled us to determine the
percentage of anthracycline molecules adsorbed to and/or
penetrating the phospholipid monolayers. In a second step,
we transferred these monolayers onto planar supports, to
study the orientation of anthracyclines by surface-enhanced
resonance Raman spectroscopy (SERRS). Indeed, this spec-
troscopy enables us to increase the Raman signal by six
orders of magnitude because of the presence of a rough
silver layer and to study the orientation of exogenous mol-
ecules in contact with lipid monolayers deposited on planar
supports, because of its short range (Kovacs et al., 1986;
Cotton, 1988; Aroca et al., 1989). Under these conditions,
the anthracycline molecules are thus integrated in the phos-
pholipid monolayers before the transfer.
We have already applied these two complementary meth-
ods to the study of the interaction of pirarubicin and adria-
mycin with monolayers of zwitterionic phospholipids
(POPC) and anionic phospholipids (POPC-DPPA 80–20
mol%) (Heywang et al., 1996, 1997). In particular, we have
shown that the orientations of these two anthracyclines in
the bilayer depend on different parameters: the nature of the
anthracycline, the charge of the phospholipid, and the mode
of preparation of the bilayer (Heywang et al., 1996, 1997).
In this work we have compared the results obtained in the
case of daunorubicin and idarubicin with those obtained in
the case of pirarubicin and adriamycin.
2. The second aspect of this work is to study the crossing
of pirarubicin through phospholipid bilayers. In this case,
we first transferred a phospholipid bilayer onto the planar
support, and then put it in contact with an aqueous solution
of pirarubicin; thus the anthracycline is initially only in
contact with the monolayer, which is far from silver. Under
these conditions, SERRS enables us, by using a particular
laboratory-built set-up, to determine if these molecules are
able to cross a phospholipid bilayer (Saint-Pierre Chazalet
et al., 1994). As a matter of fact, an aspect of the Langmuir-
Blodgett method is the possibility of preparing asymmetri-
cal preformed bilayers; the compositions of the two mono-
layers constituting the bilayer are different, as in a
biological membrane. Two types of asymmetrical bilayers
have been transferred:
POPC/POPC-DPPA bilayers: The first monolayer in con-
tact with the aqueous solution is composed of zwitterionic
POPC, and the second monolayer in contact with silver is
composed of a anionic POPC-DPPA mixture.
POPC-DPPA/POPC bilayers: The first monolayer in con-
tact with the aqueous solution of pirarubicin is composed of
a POPC-DPPA 80–20 mol% mixture, whereas the other one
(in contact with silver) is composed of POPC.
We have compared, then, these results with the behavior
of pirarubicin in contact with symmetrical POPC and
POPC-DPPA bilayers studied previously (Heywang et al.,
1996, 1997).
MATERIALS AND METHODS
Materials
Anthracyclines
Four anthracyclines were tested, adriamycin (or doxorubicin), pirarubicin
(or 4-O-tetrahydropyranyl-doxorubicin), daunorubicin, and idarubicin
(Fig. 1). They were kindly provided by Farmitalia Laboratory (Italy) and
Laboratoire Roger Bellon (France), in powder form mixed with lactose (as
for hospital use). They were dissolved in Millipore water (pH  5.5, R 
18 M) or in an organic polar solvent (dimethyl sulfoxide, DMSO) at an
initial concentration of 103 or 2  103 M. It has been checked that
lactose does not adsorb at the air-water interface.
These anthracyclines present various chemical groups on the anthraqui-
none part and the sugar, and thus the resulting hydrophobicities are
different. A possible parameter that can be used to define these differences
is the partition coefficient P of the molecules in an octanol-water system
and their resulting lipophilicity (Gallois et al., 1996). It has been shown that
the order of increasing hydrophobicity is the following: adriamycin 
pirarubicin  daunorubicin  idarubicin.
FIGURE 1 Chemical formulas of adriamycin, pirarubicin, daunorubicin,
and idarubicin, and formula of doxorubicinone (SERRS study).
Heywang et al. SERRS Study of Anthracyclines in Bilayers 2369
All of the anthracyclines used in this study are positively charged at pH
5.5, the pKa of the amino function on the sugar being 8.6 for adriamycin,
daunorubicin and idarubicin, and 7.7 in the case of pirarubicin (Frezard et
al., 1990).
Lipids
Palmitoyloleoylphosphatidylcholine (POPC, a zwitterionic phospholipid),
dipalmitoylphosphatidic acid (DPPA, an anionic phospholipid bearing one
negative charge at pH 5.5), and cholesterol were purchased from Sigma (St.
Louis, MO) and were 99% pure. They were used without further purifica-
tion and dissolved in an ethanol/chloroform 1/1 (v/v) mixture at a concen-
tration of 103 M.
Methods
Monolayers
A laboratory-built Langmuir trough was used for the preparation of the
anthracycline/lipid monolayers, using a displacement force transducer (Ka-
man Sciences Corporation, Colorado Springs, CO). This set-up has been
described in detail in previous works (Saint-Pierre Chazalet et al., 1994;
Heywang et al., 1996, 1997). The subphase was Millipore water (pH 5.5).
All experiments were performed at 21  1°C. The trough was equipped
with an electronic device that made it possible to keep the surface pressure
of the monolayer constant by monitoring the displacement of the moving
barrier. It was used during the penetration experiments and layer tranfers.
We first studied the adsorption and/or the penetration of aqueous
solutions of anthracycline (idarubicin and daunorubicin) into POPC and
POPC-DPPA (80–20 mol%) monolayers. The principle of this method is
the following. A phospholipid monolayer is spread at the interface and
compressed to 2 mN/m. This pressure is kept constant, and an aqueous
solution of anthracycline is injected under the monolayer at a final con-
centration of 1.6 M. If an interaction occurs between the anthracycline
and the monolayer, the barrier moves back to keep the pressure at 2 mN/m.
After the equilibrium (the barrier is stopped), the anthracycline-phospho-
lipid monolayer is compressed. The P/A isotherm is recorded after the
adsorption is shifted to the higher areas as compared to the pure phospho-
lipid monolayer. The difference in the mean molecular areas measured
between the two isotherms at the same pressure enables us to determine the
percentage of anthracycline in contact with lipids, by taking into account
the molecular area of the anthracycline in vacuum determined by a previ-
ous modeling study with Hyperchem software (Heywang et al., 1996).
Next, these monolayers can also be transferred by a Langmuir-Blodgett
technique onto planar supports for the SERRS study.
Preparation of planar supported symmetrical and
asymmetrical phospholipid bilayers by the
Langmuir-Scha¨fer technique
The planar supports that we used in the SERRS study are prisms made of
rutile of a high index (n  2.7). After cleaning, they are coated by vacuum
thermal evaporation with a 15-nm-thick silver layer.
The technique of transfer of planar bilayers in contact with water has
been developed in the laboratory (Saint-Pierre Chazalet et al., 1994) and
proceeds from the technique described by Tamm et al. (1985). We recall it
briefly: the prism (Fig. 2) is previously dipped into the subphase, with the
silver face perpendicular to the air-water interface. Molecules are spread at
the interface and compressed at a surface pressure of 25 mN/m. This
pressure is next kept constant at this value by the electronic device. The
prism is brought out of the subphase at 5 mm/min, and a first monolayer
is deposited on silver, with the polar headgroups of lipids in contact with
the silver layer (Saint-Pierre Chazalet et al., 1994). We can thus transfer
only a planar monolayer (see previous section, Monolayers). In the case of
a bilayer, the prism is next rotated by 90° to have the first monolayer
parallel to the interface. It is then carefully put in contact with the
monolayer remaining at the interface (Langmuir-Scha¨fer technique) and
finally fixed in a Teflon box previously put in the trough, to keep the polar
headgroups of the second layer in contact with water (Fig. 2). It is also
possible at this level to put the bilayer in contact with an aqueous solution
of the exogenous molecule.
Recording of the SERRS spectra of the planar
mono- and bilayers
Surface-enhanced Raman spectroscopy (SERS) needs the presence of a
thin silver layer (15–20 nm thick) deposited on the planar support before
the transfer of the planar mono- or bilayer (Kovacs et al., 1986). Under
these conditions, silver forms islands, which make it possible to enhance
the Raman signal of deposited molecules, which otherwise could not be
detected because of the small number of molecules and the weakness of the
signal. Electrical and chemical phenomena are responsible for the increase
in the signal at a very short distance, estimated to a few nanometers
(Cotton, 1988; Aroca et al., 1989; Saint-Pierre Chazalet et al., 1994).
Indeed, the decrease in the signal intensity is expected to follow a (a/r)12
rule, where a is the radius of the silver particle and r is the distance of the
observed point to the center of the silver particle (Cotton, 1988). Under our
experimental conditions (by taking into account the dimensions of our
silver islands), this means that the enhancement of the Raman signal
decreases by 50% at 	2 nm from the silver surface. This spectroscopy is
thus powerful for studying the behavior of anthracyclines directly in
contact with a lipid bilayer transferred to silver.
The prism was illuminated with an Ar
 laser beam, under an angle
greater than the limit angle of reflection (Fig. 2). Because of the short range
of SERS, the observed Raman spectrum is mainly due to the monolayer in
contact with silver. The SERS effect is still increased, because the used
laser wavelength is in the absorption band of the anthracyclines (surface-
enhanced resonance Raman scattering, SERRS). The scattered light is then
collected in a direction perpendicular to the surface of the sample at the
level of a microscope objective and analyzed with a Dilor (Lille, France)
triple monochromator associated with a data acquisition system. Because
the signal is weak, an accumulation of several spectra is usually performed.
FIGURE 2 Experimental set-up used for the SERRS study of the planar
anthracycline/lipid bilayers in contact with water.
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SURFACE PRESSURE AND SERRS STUDY OF
THE DAUNORUBICIN-PHOSPHOLIPID AND
IDARUBICIN-PHOSPHOLIPID INTERACTION
Results obtained by surface pressure
measurements
Behavior of idarubicin and daunorubicin at the
air-water interface
These molecules are amphiphilic and water soluble and thus
can be studied by surface pressure measurements. There-
fore, two techniques were applied to study their behavior at
the air-water interface in the absence of phospholipid (Hey-
wang et al., 1996). The first one consists of dissolving an
aqueous solution of anthracycline in the subphase (the final
concentration was 1.6 M) and observing its adsorption at
the interface. P/A isotherms are regularly recorded to mon-
itor possible adsorption. The second method consists of
spreading the anthracycline dissolved in an organic polar
solvent (DMSO) at the interface; the total number of spread
molecules is the same as the number injected into the
subphase with the first method.
Adsorption of idarubicin and daunorubicin. In the two
cases, no compression isotherm was observed after a 4- or
5-h experiment. Idarubicin and daunorubicin are thus un-
able to adsorb at the air-water interface, in contrast to
pirarubicin, which presents a weak adsorption even after 1 h
(Heywang et al., 1996).
Spreading of idarubicin and daunorubicin dissolved in
DMSO. In contrast to the previous results, idarubicin and
daunorubicin are able to remain partly at the interface after
spreading. Fig. 3 shows the isotherms obtained after the
compression (1 mm/s) of the molecules remaining at the
interface. In the case of daunorubicin, the isotherm is sim-
ilar to that with pirarubicin under the same conditions
(Heywang et al., 1996). The mean molecular areas reported
on this figure were estimated according to the total number
of molecules initially spread at the air-water interface. Their
weak values show that the number of molecules remaining
at the interface after their spreading is also very weak: an
important fraction of the spread molecules do not remain at
the interface and dissolve into the subphase before the
compression. The weak surface pressures observed on the
isotherm confirm this dissolution.
It is possible to determine the percentage of daunorubicin
at the interface from the molecular area measured on the
isotherm and an estimation of the cross section of the
anthracycline in vacuum, performed by a molecular model-
ing. This mean cross section has thus been estimated to	75
Å2. As in the case of pirarubicin, the percentage of dauno-
rubicin remaining at the interface is 	0.6% at 5 mN/m and
can be neglected compared to the percentages that we
observe in the presence of phospholipid monolayers (Hey-
wang et al., 1996, 1997 and the next section).
The isotherm of idarubicin is very different from the
daunorubicin isotherm. It presents a plateau at a surface
pressure around 6–7 mN/m. To check that this plateau was
not an artefact due to the presence of DMSO, the same
experiment was performed with idarubicin dissolved in
dimethylformamide and ethanol: the isotherms present a
plateau again. Thus we can conclude that the solvent is not
responsible for the presence of this plateau. Moreover, the
decompression isotherm (1 mm/s) shows the same plateau
at the same surface pressure.
We observe thus that 1) daunorubicin and pirarubicin
have the same behavior after their spreading at the air-water
interface, whereas daunorubicin is unable to adsorb at the
interface, in contrast to pirarubicin; 2) only the isotherm of
idarubicin spread at the interface presents a plateau at 6–7
mN/m. It has been shown that idarubicin presents aggrega-
tion properties different from those of other anthracyclines
such as daunorubicin in an hydrophobic surrounding (Gal-
lois et al., 1997). In solution, idarubicin is mainly in mo-
nomeric form, but it penetrates in lipid bilayers under a
dimeric form, whereas other anthracyclines interact with
lipids under the monomeric form. The air-water interface
can be considered as a “hydrophobic” surrounding. After
the spreading of the solution, the fraction of idarubicin
molecules remaining at the interface could thus be under a
dimer and/or aggregate form, responsible for the plateau
observed on the isotherm. That the monomers are more
water-soluble than the aggregates could also explain that no
molecule adsorbs at the air-water interface when they are
dissolved in the subphase (adsorption experiments).
Adsorption of aqueous solutions of idarubicin and
daunorubicin in phospholipid POPC and
POPC-DPPA (80–20 mol%) monolayers
The adsorption and/or penetration of idarubicin and dauno-
rubicin into phospholipid monolayers were studied next.
We have reported, as an example, in Fig. 4 the isotherms of
POPC before and after the adsorption and/or the penetration
of idarubicin (1.6 M) at 2 mN/m and determined the
resulting percentage of idarubicin kept at the interface at 25
mN/m (see Materials and Methods). The same estimation
was performed with daunorubicin under the same experi-
FIGURE 3 Compression isotherms of daunorubicin and idarubicin after
the spreading of the two anthracyclines dissolved in DMSO (pH  5.5,
T  21  1°C).
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mental conditions (data not shown). We summarized these
results in Table 1, where we also report the previous results
obtained with pirarubicin and adriamycin (Heywang et al.,
1996, 1997). We observe, in particular, that the adsorption
and/or penetration of daunorubicin and idarubicin are very
different in POPC monolayers (respectively, 7% and 17%),
whereas the percentages are all rather close in the presence
of POPC-DPPA (80–20 mol%) monolayers (respectively,
14% and 13%).
Goormaghtigh et al. (1980) also studied the interaction of
adriamycin with monolayers of zwitterionic DPPC phos-
pholipids and did not observe any adsorption of adriamycin
at the air-water interface, because of its weak hydrophobic/
hydrophilic balance. On the contrary, under our experimen-
tal conditions, we observed a weak adsorption of adriamy-
cin in zwitterionic POPC monolayers. This difference is
likely related to the different experimental conditions be-
tween the two experiments: we studied the adsorption of
adriamycin in fluid monolayers kept at a surface pressure of
2 mN/m, whereas Goormaghtigh et al. performed it in a
more condensed phase.
To complete this surface pressure study, these monolay-
ers were also tranferred onto planar supports and studied by
SERRS.
Results
Results obtained with SERRS
The previous monolayers of daunorubicin/phospholipid and
idarubicin/phospholipid were transferred by the Langmuir-
Blodgett technique onto rutile planar supports coated with a
thin silver layer, and their SERRS spectra were recorded to
estimate the orientation of the anthracyclines.
Anthracyclines present very complex Raman spectra be-
tween 400 and 1800 cm1. One of the most important
problems is the assignment of their bands. Therefore differ-
ent studies have already focused on this point (Smulevich et
al., 1986, 1988; Nonaka et al., 1990; Nabiev et al., 1991,
1994). They have been determined by
1. Comparison between the resonant Raman (RR) and
SERRS spectra of different anthracyclines and their chro-
mophore models such as anthraquinones (in all of the
SERRS studies, the SERRS spectra of the anthracyclines
were recorded in aqueous solution with colloids prepared
according to the procedures of Creighton or Lee-Meisel);
2. Changes in the experimental conditions (pH, ionic
strength. . . );
3. Comparison with results of other methods such as
fluorescence, resonant Raman, and infrared spectroscopies
(Angeloni et al., 1982; Smulevich et al., 1982; Dutta et al.,
1986).
Some of the major observations and results are the fol-
lowing. The Raman spectra of anthracyclines such as adria-
mycin are modified when the pH of the aqueous solution is
increased (Dutta et al., 1986). Some bands are less intense
or disappear and are thus assigned to (C-O-H) deforma-
tions (band at 	1210 cm1, for instance). The frequency of
some other bands is shifted as the result of the appearance
of phenolate functions that increase the electronic density
on the chromophore. They are assigned to cycle vibrations.
At last, some bands are not sensitive to pH modifications
and are assigned, for instance, to the methoxy function
-OCH3.
In the case of adriamycin and aclacinomycin, some bands
between 1200 and 1300 cm1 also disappear after deutera-
tion; this confirms the importance of the hydroxyl groups
(-OH) in this region of the Raman spectrum. Finally, the
Raman spectra of the chromophore models are very close to
the spectra of anthracyclines, which suggests that the spec-
tra are mainly related to the dihydroxyanthraquinone part of
anthracyclines. Table 2 presents the frequencies and the
assignment of some of these bands.
In our previous work (Heywang et al., 1996), this spec-
troscopy was first applied to the study of pirarubicin, adria-
mycin, and doxorubicinone molecules (doxorubicinone cor-
responding to the anthraquinone part of pirarubicin and
adriamycin without the sugar and the THP group; Fig. 1).
The SERRS spectra of pirarubicin and doxorubicinone are
reported in the inset of Fig. 5. We observed, for instance, in
the case of the aqueous solution of pirarubicin, that the
aromatic rings are close to silver, whereas the tetrahydro-
FIGURE 4 POPC compression isotherms before (a) and after (b) pene-
tration of idarubicin (C  1.6 M, pH  5.5, T  21  1°C; the pressure
during the compression was kept constant at 2 mN/m).
TABLE 1 Estimated percentages of anthracyclines at the
interface (P  25 mN/m) after adsorption and/or penetration
in the different lipid monolayers
Adsorption experiments
Adriamycin Pirarubicin Daunorubicin Idarubicin
POPC 4%** 11%* 7% 17%
POPC-DPPA
(80–20 mol%)
11%** 13%** 14% 13%
C  1.6 M, pH  5.5, T  21  1°C. The surface pressure was kept
constant at 2 mN/m.
*Heywang et al. (1996).
**Heywang et al. (1997).
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pyren (THP) group is far from it. A possible orientation
could thus be the following. The long axis of the anthra-
quinone part would be perpendicular or tilted to the silver
coating. In the case of doxorubicinone, its SERRS spectrum
suggests that the aromatic rings would be in contact with
silver and parallel to the silver surface (“lying” configura-
tion). The observed differences could be induced by the fact
that doxorubicinone is “cleared” of the sugar and THP
group. Finally, the SERRS spectrum of adriamycin also
demonstrated that the anthraquinone part of this molecule
would be lying on silver as doxorubicinone (Heywang et al.,
1997).
Because the SERRS spectrum of anthracyclines is related
mainly to the anthraquinone part, we used this characteristic
to estimate, in a second step, the orientation of this anthra-
quinone part and thus the orientation of the whole molecule
in lipid planar monolayers (Heywang et al., 1996, 1997).
This orientation depends on 1) the nature of the anthracy-
clines, 2) the charge of phospholipids, and 3) the mode of
preparation of the bilayers.
In the 900-1800 cm1 region, two parasite broad bands at
1375 and 1590 cm1 are always superimposed on the an-
thracycline spectrum (Saint-Pierre et al., 1994). These
bands are assigned to the graphitized carbon resulting from
a photochemical reaction between CO2 present in air or
water and the silver layer (Nabiev et al., 1988). They are
always subtracted from the subsequent SERRS spectra. We
will not take into account the 1500–1800 cm1 region in
our following interpretations because of this subtraction (the
band at 1590 cm1 is the more intense).
Finally, the integrity of the planar phospholipid mono-
layers and bilayers was checked for each transfer by ob-
serving the 2750–3050 cm1 region. In this region, the
vibration modes of phospholipids are mainly observed. In
particular, the presence of an intense band at 2960 cm1
(assigned to the asymmetrical stretching vibration of the
methyl groups) is intense in the case of phospholipid bilay-
ers (Saint-Pierre Chazalet et al., 1994).
SERRS study of planar daunorubicin/
phospholipid monolayers
We began this study by the recording of the SERRS spec-
trum of a daunorubicin aqueous solution and then per-
TABLE 2 Principal assignments of the vibrational modes observed in the different SERRS spectra of anthracyclines and
anthracycline/lipid mono- and bilayers
Frequency (cm1) 980 1206 1240 1260 1400–1410 1450
Assignments Ring breath (C-O-H)
in plane
(C-O-H)
in plane
Ring stretch Ring stretch Ring stretch (CH2),
THP group in the
case of pirarubicin
SERRS spectrum of an aqueous solution
of pirarubicin (1 M), (*)
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/ symbols indicate whether the band is very intense, intense, visible, or invisible. “s” indicates that the band appears as a shoulder. The
question mark (?) indicates the ambiguous cases.
*Heywang et al. (1996).
Heywang et al. SERRS Study of Anthracyclines in Bilayers 2373
formed the spectra of planar daunorubicin/phospholipid
monolayers. It has to be noted that the SERRS spectrum of
the aqueous solutions of anthracyclines corresponds mainly
to molecules that are close to the silver coating: molecules
dissolved in the solution and far from silver are not ob-
served because of the short range of SERRS (see Recording
of the SERRS spectra of the planar mono- and bilayers,
above). It was also checked in the case of pirarubicin that
the anthracycline does not interact with silver. A prism
previously coated with silver and dipped into an aqueous
solution of pirarubicin was brought out after 30 min and
observed in SERRS. The SERRS spectrum of pirarubicin
was not observed, showing that pirarubicin molecules do
not remain adsorbed on silver (data not shown). Thus if an
interaction occurs between the anthracycline and silver, it is
too weak as compared to the solubilization of the anthracy-
cline into the subphase.
SERRS spectrum of an aqueous solution of daunorubicin.
Fig. 5 a shows the SERRS spectrum of an aqueous solution
of daunorubicin at 10 M deposited on a prism. We observe
the bands at 1206 and 1240 cm1 ((C-O-H)) and 1400
cm1 (ring stretch). No band is observed at 1260 cm1 (or
FIGURE 5 (a) SERRS spectrum of an aqueous
solution of daunorubicin (C  10 M, pH  5.5).
(b) SERRS spectrum of an “adsorbed” daunorubi-
cin/POPC monolayer after penetration of an aque-
ous solution of daunorubicin in a POPC monolayer.
(c) SERRS spectrum of an “adsorbed” daunorubi-
cin/POPC-DPPA 80–20 mol% monolayer after
penetration of an aqueous solution of daunorubicin
in a POPC-DPPA 80–20 mol% monolayer. (Inset)
SERRS spectrum of an aqueous solution of piraru-
bicin (C  1 M, pH  5.5) and SERRS spectrum
of doxorubicinone powder. Experimental condi-
tions for the preparation of the monolayers: C 1.6
M, pH  5.5, T  21  1°C; the surface pressure
was kept at 2 mN/m during the penetration, and the
penetration time was limited to 15 min.
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it is so weak that it disappears in the base of the intense band
at 1240 cm1). The band at 1450 cm1 appears as a shoulder.
On the whole, this spectrum is rather close to the SERRS
spectrum of the aqueous solution of pirarubicin, even if the
intensity of the band at 980 cm1 is weak. This suggests that
the anthraquinone part of daunorubicin thus has the same
orientation as the pirarubicin part. The major part of the
molecules would be perpendicular to the silver coating.
SERRS spectra of daunorubicin/POPC planar monolay-
ers. Daunorubicin/POPC planar monolayers were trans-
ferred to prisms after the adsorption of an aqueous solution
of daunorubicin (1.6 M) in a POPC monolayer (“ad-
sorbed” monolayers). Under these conditions, the percent-
age of daunorubicin remaining in contact with POPC is
estimated to be	7%. The SERRS spectrum of these mono-
layers is presented in Fig. 5 b.
This spectrum is different from the spectrum of the aque-
ous daunorubicin solution: in particular, we observe a band
at 1260 cm1 that is intense and more or less overlaps the
band at 1240 cm1. This last band is also intense (its
intensity is similar in this spectrum and in the solution
spectrum), even if it seems to be weaker; this is related to
the overlapping with the band at 1260 cm1. The band at
1206 cm1 is very weak (the broad base of the band at
1240–1260 cm1 has to be taken into account). At last the
band at 1400 cm1 is thin and very intense, as compared to
the same band in the SERRS spectrum of the daunorubicin
solution.
This second spectrum is close to that of doxorubicinone;
therefore, it could be suggested that in the “adsorbed”
daunorubicin/POPC monolayers, the major part of the
daunorubicin molecules is lying on silver and thus is ad-
sorbed to the polar headgroups of phospholipids. The small
differences between the spectra of doxorubicinone and
daunorubicin/POPC monolayers could be assigned to the
presence of phospholipids and some daunorubicin mole-
cules embedded in phospholipid chains. However, the mol-
ecules mainly observed are very close to the silver coating.
SERRS spectra of daunorubicin/POPC-DPPA (80–20
mol%) planar monolayers. As previously noted, we recorded
the SERRS spectrum of “adsorbed” daunorubicin/POPC-
DPPA 80–20 mol% monolayers, under the same experimental
conditions. The percentage of daunorubicin in contact with
phospholipid is estimated to be 	14%. This spectrum (Fig. 6
c) is similar to the SERRS spectrum of “adsorbed” daunoru-
bicin/POPCmonolayers and suggests that the major part of the
FIGURE 6 (a) SERRS spectrum of an aqueous solu-
tion of idarubicin (C  10 M, pH  5.5). (b) SERRS
spectrum of an “adsorbed” idarubicin/POPC monolayer
after penetration of an aqueous solution of idarubicin in
a POPC monolayer. (c) SERRS spectrum of an “ad-
sorbed” idarubicin/POPC-DPPA 80–20 mol% mono-
layer, after penetration of an aqueous solution of idaru-
bicin in a POPC-DPPA (80–20 mol%) monolayer.
Experimental conditions for the preparation of the
monolayers: C 1.6 M, pH 5.5, T 21 1°C; the
surface pressure was kept at 2 mN/m during the pene-
tration, and the penetration time was limited to 15 min.
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daunorubicin molecules would also be lying on silver and
adsorbed to the polar headgroups of phospholipids.
SERRS study of planar idarubicin/phospholipid monolayers
As previously, the SERRS spectrum of an aqueous solution
of idarubicin was recorded before the SERRS spectra of
idarubicin/phospholipid planar monolayers.
SERRS spectrum of an aqueous solution of idarubicin.
The SERRS spectrum of an aqueous solution of idarubicin
(10 M) is presented in Fig. 6 a. First we can observe that
this spectrum is not as well-resolved as the spectrum of
daunorubicin at the same concentration. However, we can
observe broad bands between 1240 and 1260, 1425 or
1600–1700 cm1, and a weaker band at 960 cm1.
Moreover, the band at 1206 cm1 assigned to the (C-
O-H) vibration is missing. This can be explained by the
chemical structure of the anthraquinone part of idarubicin:
the Rs group is (H) instead of (OCH3) in the other three
anthracyclines (Fig. 1). This anthraquinone part is thus
symmetrical along the long axis of the anthraquinone and
the frequencies of the angular deformations of the two
(C-O-H) groups are similar, with the presence of the cyclo-
hexyl A (Fig. 1) condensed to the anthraquinone part in-
ducing only small perturbations in the symmetry of the
chromophore. A single band around 1240 cm1 appears,
instead of two bands at 1206 and 1240 cm1.
Finally, the bad quality of the spectrum is probably re-
lated to the absence of the (-OCH3) group; indeed, Smulev-
ich et al. studied adriamycin, epirubicin, and idarubicin and
proposed that the methoxy group at the end of the anthra-
quinone part likely promotes the bonding of the anthracy-
cline to their silver colloid by increasing the polarity of the
CAO group (Smulevich et al., 1988).
The relative intensities of the two bands at 1206 and 1240
cm1 were a parameter used in the previous studies to
determine the orientation of pirarubicin and adriamycin
(Heywang et al., 1996, 1997). Therefore, it is difficult to
determine the orientation of idarubicin on silver in the
absence of these two bands.
SERRS spectra of idarubicin/POPC and idarubicin/
POPC-DPPA (80–20 mol%) planar monolayers. “Ad-
sorbed” idarubicin/POPC and idarubicin/POPC-DPPA
monolayers (containing, respectively, 17% and 12.6% of
idarubicin, as shown by surface pressure measurements)
were transferred, and their spectra were next compared to
the idarubicin aqueous solution. Fig. 6, b and c, presents the
SERRS spectra of these monolayers. In the two cases, the
spectra are better than the spectrum of the aqueous solution
of idarubicin, because the bands are narrow and more well
resolved, in particular the band at 1260 cm1. The better
quality of these spectra could be related to the presence of
the phospholipid monolayers, which would maintain the
idarubicin molecules close to the silver coating. Moreover,
these two spectra are rather close. This suggests that idaru-
bicin has a similar orientation in the two types of monolay-
ers, and that this orientation is not modified by the presence
of anionic DPPA in the monolayer. However, it is not pos-
sible to precisely describe this orientation.
DISCUSSION
The major results of this study can be summarized as
follows.
1. In the case of the adsorption of the anthracycline
molecules to a POPC monolayer, the percentages of anthra-
cycline remaining at the interface at 25 mN/m increase from
4% to 17% in the following order: adriamycin  daunoru-
bicin  pirarubicin  idarubicin (Table 1). Except in the
case of pirarubicin, the percentage increases with the hy-
drophobicity of the anthracycline (Gallois et al., 1996); in
the presence of zwitterionic phospholipids it seems that the
hydrophobicity is the major component of the interaction.
The previous SERRS studies and the new results also con-
firm the importance of this hydrophobic/hydrophilic bal-
ance of the anthracycline to its location in the membrane; as
in the case of the “adsorbed” adriamycin/POPC monolay-
ers, the SERRS spectrum of the “adsorbed” daunorubicin/
POPC monolayer suggests that the major part of the dauno-
rubicin molecules would not penetrate deep into the POPC
monolayer and would remain adsorbed on the polar head-
groups.
Although our results are obtained with monolayers as a
membrane model, they are consistent with previous obser-
vations of Burke and Tritton (1985a,b), who studied the
interaction of eight daunorubicin analogs with fluid-phase
dimyristoylphosphatidylcholine and solid-phase DPPC ves-
icles. These analogs all differed by a chemical modification
of the chromophore, changing the overall hydrophobicity of
the molecules. Burke and Tritton have shown that the de-
crease in the anthracycline hydrophobicity strongly reduces
the membrane affinity of the anthracycline. In particular, the
affinity for fluid membranes was higher in the case of
daunorubicin than in the case of adriamycin. Later, they
performed another study with a positively charged anthra-
cycline presenting a hydrophobic valerate group on the
chromophore (Burke et al., 1989). This hydrophobic mod-
ified antibiotic presents a comparable selectivity for lipo-
somes containing zwitterionic (dimyristoylphosphatidyl-
choline) and anionic (dimyristoylphosphatidylglycerol)
phospholipids, in contrast to other, less hydrophobic anthra-
cyclines devoid of this valerate group, which have a strong
affinity for anionic liposomes only.
In the case of pirarubicin, it seems that this anthracycline
presents a particular behavior: the percentage of drug re-
maining at the interface after the adsorption in a POPC
monolayer is higher than that of daunorubicin, whereas the
hydrophobicities of these two compounds are inverted. This
particular behavior is likely to be related to the presence of
the additional hydrophobic THP group. This group also
seems to play an important role in the incorporation of
pirarubicin into POPC bilayers: our previous SERRS study
suggested that pirarubicin was embedded in the phospho-
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lipid chains in the “adsorbed” POPC monolayers (Heywang
et al., 1996).
Finally, the surface pressure study shows that the per-
centage of idarubicin at the interface is higher than that
obtained with the three other antibiotics (Table 1), suggest-
ing that the hydrophobic interactions are at maximum. Un-
fortunately, it is not possible to estimate the orientation of
idarubicin on the silver coating: some bands, which are
usually used to determine the orientation, are missing, and
the SERRS spectrum of the aqueous solution is not well
resolved. Under these conditions, it is not possible to com-
pare the solution and monolayer spectra.
2. In the case of the adsorption of the anthracycline
molecules to a POPC/DPPA (80–20 mol%) monolayer,
from the results reported on Table 1, the anthracyclines can
be separated in two groups. The first group concerns adria-
mycin and daunorubicin. For these molecules, the percent-
ages kept at the interface are higher in the presence of
anionic DPPA in the monolayer; the percentages of adria-
mycin and daunorubicin are, respectively, 4% and 7.2% in
the presence of a POPC zwitterionic monolayer, and 11% and
14.3% in the presence of a POPC-DPPA anionic monolayer.
Thus the presence of negative charges at the interface
increases these percentages: the electrostatic component of
the interaction is favored as compared to the hydrophobic
component. This higher selectivity for the negatively
charged phospholipids, observed in the case of monolayers,
is in agreement with previous studies performed with adria-
mycin and daunorubicin. For instance, de Wolf et al. (1993)
studied the affinity of adriamycin for mixed DOPC/DOPG
anionic liposomes and observed that the overall fixation of
adriamycin to liposomes is determined by the percentage of
anionic phospholipids in the bilayer. Escriba et al. (1990)
observed by fluorescence anisotropy the same increase in
the daunorubicin affinity for liposomes in the presence of
phosphatidylserine or other anionic phospholipids. Finally,
Constantinides et al. (1986) showed by differential scanning
calorimetry that adriamycin had the same selectivity for
anionic vesicles. The presence of adriamycin does not affect
the phase transition properties of multilamellar vesicles of
DPPC, whereas the thermogram of DPPG vesicles is highly
perturbed at the same concentration of adriamycin. This
difference in behavior is related to a higher electrostatic
interaction between adriamycin and DPPG. This strong
electrostatic interaction could also be responsible for the
orientation of adriamycin and daunorubicin in phospholipid
monolayers observed in SERRS: indeed the SERRS results
suggest that only some molecules could penetrate into the
phospholipid chains and that the major part would remain
adsorbed on the polar headgroups. This adsorption at the
water-phospholipid polar headgroup interface has also been
described in the case of adriamycin in interaction with
anionic phospholipids (de Wolf et al., 1991) or with cardi-
olipin. Nicolay et al. (1988) proposed that the orientation of
adriamycin in interaction with cardiolipin monolayers de-
pends on the surface pressure and the adriamycin/cardio-
lipin ratio. In particular, in the 2/1 complex, the chro-
mophore would be at the water-polar headgroup interface,
whereas it would be more embedded at a weaker ratio.
The second group concerns pirarubicin and idarubicin.
The percentages of pirarubicin and idarubicin are, respec-
tively, 11% and 17% in the presence of a POPC zwitterionic
monolayer, and 13% and 12.6% in the presence of a POPC-
DPPA anionic monolayer. Thus, in contrast to the two
previous molecules, the percentage of pirarubicin is not
drastically increased in the presence of anionic DPPA, as
compared to the percentage in the presence of pure POPC
monolayers. In the case of idarubicin, the percentage re-
maining at the interface in the presence of DPPA is even
weaker than in the presence of POPC.
The previous surface pressure and SERRS studies dem-
onstrated that pirarubicin, despite its higher hydrophobicity,
does not penetrate the phospholipid chains of the POPC-
DPPA monolayers and is adsorbed to the polar headgroups
of phospholipids, forming a screen. This screen would
hinder a deeper penetration of the other molecules dissolved
in the subphase, limiting the final percentage of pirarubicin
at the interface (Heywang et al., 1997). Such a screen could
also be formed by idarubicin adsorbed to the polar head-
groups: the good resolution of the SERRS spectrum of
“adsorbed” idarubicin/POPC-DPPA suggests that the major
part of idarubicin could be out of the monolayer. However,
it is not possible to check this hypothesis.
Finally, these results are partly in agreement with previ-
ous results obtained by Gallois et al., who estimated by
fluorescence the depth of the chromophore of 12 anthracy-
cline derivatives in phosphatidylcholine liposomes contain-
ing variable percentages of phosphatidic acid and choles-
terol (Gallois et al., 1996). They observed that the
chromophore of adriamycin and daunorubicin is localized in
the middle of the polar headgroup region, whereas the
pirarubicin chromophore would be slightly deeper in the
polar headgroup region, perhaps partially in the hydrocar-
bon phase. In our case it is not possible to observe such
differences. However, Gallois et al. performed their study
on liposomes, whereas we used monolayers as a simplified
membrane model. In the case of monolayers, there is no
aqueous phase to dissolve the anthracyclines after their
crossing. This certainly limits the incorporation of anthra-
cycline deeper in the monolayer.
SERRS STUDY OF PLANAR ASYMMETRICAL
BILAYERS IN CONTACT WITH AN AQUEOUS
SOLUTION OF PIRARUBICIN
The previous study enabled us to precisely describe the
interaction of anthracyclines with phospholipid monolayers.
Another aspect of this work is to determine whether the
anthracyclines, put in the presence of a phospholipid planar
bilayer, are able to cross this bilayer. Under these condi-
tions, SERS is a powerful method. Indeed, in the case of
planar bilayers put in contact with an aqueous solution of
anthracycline, the bilayer separates the anthracycline from
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the silver layer. If the anthracycline does not cross the
bilayer, it remains too far from the silver coating to give a
usable spectrum. On the contrary, if the anthracycline
crosses the bilayer, we can observe its SERRS spectrum and
determine the orientation of the anthraquinone part of the
anthracycline and thus the orientation of the whole mole-
cule. By using the experimental set-up built in our labora-
tory (Saint-Pierre Chazalet et al., 1994), it is thus possible to
observe whether the anthracycline crossed the bilayer. Fi-
nally, one of the characteristics of the Langmuir-Blodgett
method is the ability to transfer asymmetrical phospholipid
bilayers kept in contact with water, to study the interaction
of anthracycline with a membrane model taking into ac-
count the asymmetry of biological membranes.
In our previous work, we studied the behavior of piraru-
bicin in contact with symmetrical phospholipid bilayers, the
composition of the two monolayers being the same. Piraru-
bicin was first put in contact with symmetrical POPC bi-
layers. (Heywang et al., 1996). Two concentrations were
studied: 0.4 and 2 M. In the two cases, we observed the
SERRS spectrum of pirarubicin, showing that the molecule,
initially separated from silver by the bilayer, is able to cross
the POPC bilayer. Moreover, its orientation depends on the
concentration. At weak concentration, the anthraquinone
part of pirarubicin would be perpendicular or tilted on silver
and thus parallel to the phospholipid chains. A possible
interpretation is the following: pirarubicin would remain
embedded in phospholipids and would not go completely
out of the bilayer. At higher concentration, pirarubicin
would be lying on silver; in this case, the major part of the
pirarubicin molecules would go out completely and would
remain in contact with the polar headgroups of phospholip-
ids. Because of the short range of SERS, we observe mainly
the molecules that completely crossed the phospholipid
bilayer and are thus localized between the polar headgroups
and the silver coating.
Symmetrical bilayers of POPC-DPPA (80–20 mol%)
were also put in contact with an aqueous solution of pira-
rubicin. In all cases, pirarubicin would be lying on silver in
contact with the polar headgroups of phospholipids; the
major part of pirarubicin molecules would go completely
out of the bilayer (Heywang et al., 1997). This result is
correlated with the results obtained by surface pressure
measurements and SERRS; in the case of pirarubicin inter-
acting with anionic phospholipid monolayers, the anthracy-
cline would remain adsorbed on polar headgroups.
However, the composition of a biological membrane is
not the same in the two monolayers, because the inner layer
contains, for instance, more anionic phospholipids than the
outer layer (Devaux et al., 1991). To get closer to the condi-
tions of the biological membranes, two types of asymmetrical
bilayers have been transferred; these are presented in Fig. 7:
POPC/POPC-DPPA bilayers: The first monolayer in con-
tact with the aqueous solution is composed of POPC, and
the second monolayer in contact with silver is composed of
a POPC-DPPA mixture.
FIGURE 7 Summary of the different
SERRS results obtained in the case of
pirarubicin in contact with symmetrical
and asymmetrical phospholipid bilayers.
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POPC-DPPA/POPC bilayers: The first monolayer in con-
tact with the aqueous solution of pirarubicin is composed of
a POPC-DPPA 80–20 mol% mixture, whereas the other one
(in contact with silver) is composed of POPC. Their SERRS
spectra are presented in Fig. 8.
SERRS spectrum of asymmetrical preformed bilayers of
POPC/POPC-DPPA in contact with an aqueous solution of
pirarubicin 0.4 M (Fig. 7 III). The spectrum (Fig. 8 a)
shows the presence of pirarubicin molecules close to the
silver coating: these molecules, initially separated from
silver by the presence of the bilayer, have crossed the
bilayer to come close to the metal. However, the spectrum
is not very intense, which suggests that only some mole-
cules crossed the bilayer.
Despite the rather bad quality of this spectrum, it is
possible to observe a broad band between 1240 and 1260
cm1 corresponding to the overlapping of these two peaks.
Moreover, the band at 1206 cm1 is weak, and the band at
1400–1410 cm1 is broad and not well resolved. Even if
this spectrum is rather difficult to analyze, it seems to be
closer to the doxorubicinone spectrum; that could be an
indication that the few molecules of pirarubicin that crossed
the bilayer are lying on silver.
SERRS spectrum of asymmetrical preformed bilayers of
POPC-DPPA/POPC in contact with an aqueous solution of
pirarubicin (0.4 or 2 M) (Fig. 7 IV). At weak concentra-
tion (0.4 M), the spectrum (Fig. 8 b) does not show the
presence of pirarubicin close to silver: only the two broad
bands of graphitized carbon are observed. The range of
SERRS being short, this means that pirarubicin does not
cross the bilayer under these conditions.
When the concentration is increased at 2 M, the spec-
trum shows the presence of pirarubicin molecules close to
the silver coating (Fig. 8 c). On the whole, the spectrum is
rather similar to the SERRS spectrum of pirarubicin in
aqueous solution, even if the band at 980 cm1 is strongly
diminished. In this last case, the major part of the pirarubi-
cin molecules would be perpendicular or tilted on the silver
layer and would remain embedded in the phospholipid
chains of the monolayer in contact with silver; under these
conditions, pirarubicin does not completely cross the bilayer.
DISCUSSION
The results obtained with the asymmetrical bilayers are
reported in Fig. 7 and compared with the previous results
obtained with the symmetrical bilayers (Heywang et al.,
1996, 1997).
We observe that pirarubicin at weak concentration in
contact with a first monolayer of POPC (POPC/POPC-
FIGURE 8 (a) SERRS spectrum of an asymmetrical
bilayer of POPC (monolayer in contact with water)/
POPC-DPPA 80–20 mol% (monolayer in contact with
silver) put in contact with an aqueous solution of pira-
rubicin (C  0.4 M, pH  5.5). (b) SERRS spectrum
of an asymmetrical bilayer of POPC-DPPA 80–20
mol%/POPC put in contact with an aqueous solution of
pirarubicin (C  0.4 M, pH  5.5). The spectrum of
graphitized carbon has not been subtracted. (c) SERRS
spectrum of an asymmetrical bilayer of POPC-DPPA
80–20 mol%/POPC put in contact with an aqueous
solution of pirarubicin (C  2 M, pH  5.5).
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DPPA bilayers, Fig. 7 III) is able to cross the bilayer and to
go out completely. In contrast, if the first monolayer is
negatively charged (POPC-DPPA/POPC bilayers, Fig. 7
IV), pirarubicin at the same concentration is unable to cross
the bilayer. The surface pressure study has shown that
pirarubicin molecules adsorbed to the polar headgroups of
DPPA form a screen limiting the deeper penetration of other
molecules (Heywang et al., 1997).
The SERRS results suggested that the pirarubicin mole-
cules, transferred after their adsorption to a anionic mono-
layer, remained in contact with the polar headgroups of phos-
pholipids. This could explain why the pirarubicin molecules
are kept at the interface in the case where pirarubicin is initially
in contact with a POPC-DPPA/POPC bilayer. However, pira-
rubicin is able to cross the bilayer if the concentration of the
solution is increased to 2 M; only a weak fraction of the
molecules penetrates the bilayer. This higher concentration
makes it possible to remove the obstacle of the adsorbed
molecules because of a higher concentration gradient.
The crossing of pirarubicin through the bilayer is also
favored by the presence of negative charges in the second
monolayer. At weak concentration (Fig. 7 I), pirarubicin is
able to cross a symmetrical POPC bilayer but remains
embedded in the POPC chains without going out com-
pletely. In the presence of DPPA in the second monolayer
(Fig. 7 III), we observe, despite the bad quality of the
spectrum, that a few molecules of pirarubicin cross the
bilayer, go out completely, and thus are parallel to the silver
coating. This is likely to be related to the presence of
anionic DPPA, which favors the crossing of molecules by
the electrostatic interaction. This aspect is confirmed by the
comparison of bilayers II and IV: when the first monolayer
is negatively charged (POPC-DPPA/POPC bilayers), pira-
rubicin cannot cross the bilayer, probably because of the
screen formed by the adsorbed molecules. However, if
DPPA is also present in the second monolayer (Fig. 7 II),
pirarubicin crosses the bilayer completely because of the
presence of the negative charges in the second monolayer.
These results suggest that the behavior of pirarubicin is
different when the molecule is in contact with the outer or
the inner monolayer of a cellular membrane; the penetration
of pirarubicin into the cell from the surrounding medium by
passive diffusion (our membrane model is devoid of any
energy system) would be easier than its exit, because this exit
would be limited by the adsorption of molecules to the nega-
tive polar headgroups. This behavior has also been proposed in
the case of adriamycin by Speelmans et al. (1994), who ana-
lyzed the kinetics of passive transport of this anthracycline in
DNA-containing liposomes. They observed that the presence
of anionic phospholipids decreases the permeability coefficient
of adriamycin. This inhibitory effect is likely to be related to a
tightening of the polar headgroups induced by the presence of
anionic phospholid-adriamycin complexes at the solvent-
polar headgroup interface.
This conclusion is different from the conclusion proposed
by Frezard et al. (1997), who studied the incorporation of
three anthracyclines (adriamycin, daunorubicin, and piraru-
bicin) in DNA-containing vesicles of different composi-
tions. They observed, as did Speelmans et al., a decrease in
the permeability coefficient of anthracycline through the
membrane in the presence of anionic phospholipids. How-
ever, they assigned it to a decrease of the amount of the
anthracycline neutral form embedded in the membrane re-
sulting from the presence of anionic phospholipids, the
neutral form being the only form that is able to cross the
membrane by passive diffusion.
CONCLUSION
The design of new derivatives of anthracyclines is a major
challenge in chemotherapy. It implies a better understand-
ing of the anthracycline-membrane interaction. In this work,
it has been shown that surface pressure measurements and
SERS are two powerful and complementary methods for the
study of anthracycline-membrane interactions. In particular,
the comparison of the behavior of four different anthracy-
clines (adriamycin, daunorubicin, pirarubicin, and idarubi-
cin) underlined the importance of the hydrophobic compo-
nent of anthracycline in its interaction with phospholipid
monolayers.
However, phospholipid monolayers are not a completely
realistic membrane model, because they can give informa-
tion about the interaction of anthracyclines with only one
side of the membrane. Therefore it is important to complete
this kind of work with the study of the diffusion of anthra-
cyclines through phospholipid bilayers. At this level, a
significant aspect of the Langmuir-Blodgett technique is the
ability to transfer symmetrical and asymmetrical phospho-
lipid bilayers. The SERS study was thus divided into two
complementary parts: the first one, coupled with the surface
pressure study, made it possible to estimate the orientation
of anthracyclines previously integrated into a phospholipid
monolayer before the transfer. The second one consisted of
observing the possible passive diffusion of pirarubicin
through asymmetrical phospholipid bilayers. The results
observed in this second part were interpretated on the basis
of the hypotheses proposed after the first study. In particu-
lar, the study of the interaction of pirarubicin with asym-
metrical DPPA-containing bilayers suggests that this anti-
biotic would easily penetrate the cells, whereas its exit by
passive diffusion in the extracellular medium would be
limited by the presence of anionic phospholipids in the inner
layer of the membrane. However, two opposite phenomena
could occur at the same time: after the penetration of the
cells 1) pirarubicin molecules would dissolve in the cyto-
plasm, but 2) some pirarubicin molecules could remain
adsorbed to the inner layer of the membrane because of the
electrostatic interaction with anionic phospholipids; the up-
take by the P-gp would be easier, and these molecules
would be ejected from the cells (Speelmans et al., 1994).
However, it is difficult to be more precise, because our
membrane model is not complete; the motions of the an-
thracycline adsorbed to polar headgroups are limited be-
cause of the presence of the planar support.
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Finally, we also do not take into account the difference in
fluidity between the two leaflets of the bilayer. This param-
eter probably plays an important role in the incorporation of
anthracyclines into membrane, because the presence of cho-
lesterol or sphingomyeline, which decreases the membrane
fluidity, limits the penetration of anthracyclines (Speelmans
et al., 1994). This aspect of the anthracycline-membrane
interaction will be treated in a later study.
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